Viewing StudyNCT06613880



Ignite Creation Date: 2024-10-26 @ 3:41 PM
Last Modification Date: 2024-10-26 @ 3:41 PM
Study NCT ID: NCT06613880
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-23

Brief Title: Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
Sponsor: None
Organization: None

Conditions & Keywords Data

Conditions:
Keywords: